Analyse Sonendo, Inc. (SONX) — Kairos Score 45/100

À propos de Sonendo, Inc.

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for endodontists. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.

Informations clés

🕴️ Activité des initiés (90 jours)

0 transactions — 0 achats et 0 ventes déclarés par les dirigeants de Sonendo, Inc..

🏦 Hedge Funds

0 fonds institutionnels déclarent une position sur SONX dans leur dernière déclaration trimestrielle SEC.

📰 Actualités récentes

2 articles récents sur SONX.

• Sonendo Achieves Milestone of Two Million Patients Treated with the GentleWave® Procedure
• Sonendo Announces Key Initiatives to Drive Business Towards Cashflow Break-Even

🧠 Ce qui fait Kairos Insider

Au-dela des donnees brutes, nous agregeons et scoring tout le signal smart money pour vous donner une vue unique.